High-power short-duration vs conventional radiofrequency ablation for atrial fibrillation in patients over 80 years of age: A propensity-score matched cohort analysis

高功率短时射频消融术与传统射频消融术治疗80岁以上房颤患者的疗效比较:一项倾向评分匹配队列分析

阅读:1

Abstract

BACKGROUND: Data on atrial fibrillation (AF) ablation using high-power short-duration (HPSD) ablation in patients over 80 years are lacking. OBJECTIVE: This study aimed to compare the safety and efficacy of paroxysmal and persistent AF ablation using an HPSD (60-90 W/4-8 sec) vs conventional ablation (30-40 W/30 sec) in a propensity score-matched cohort of patients older than 80 years. METHODS: Overall, 232 consecutive patients aged over 80 years undergoing AF ablation were included. Propensity score matching revealed 102 pairs for maximizing comparability. A post-ablation 42-day blanking period was applied. Major complications were defined as those requiring intervention or causing sequels within 30 days following catheter ablation. RESULTS: Procedural duration (132.7 ± 45.7 vs 155.4 ± 59.7 min; P = .0062) and x-ray exposure (dose area product 248.9 ± 313.6 vs 544.9 ± 704.7 cGycm(2); P = .0002) were significantly reduced in the HPSD group. Safety end points showed no significant differences (4/102 vs 7/102; P = .54). Freedom from any arrhythmia was not different between the groups including a follow-up of 22.5 ± 22.7 months (hazard ratio, 0.71; 95% confidence interval, 0.48-1.06 for the HPSD approach). After 1.52 ± 0.79 procedures, 80.4 % of all patients remained in sinus rhythm with a lower number of repeat procedures in the HPSD group (1.38 ± 0.65 vs 1.65 ± 0.90; P = .038). CONCLUSIONS: In very old patients (>80 years), AF ablation using an HPSD approach can be performed safely and effectively with a reduction of procedure duration, x-ray exposure, and fewer repeat ablations compared to a conventional approach. Long-term ablation results are promising with both approaches.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。